Dr. Shili Xu received a B.S. in Biological Sciences and a B.S. in Economics from Peking University. He received a Ph.D. from the University of Southern California where he studied small-molecule drug design and discovery. He then studied cell metabolism, molecular imaging, and synthetic lethality for cancer therapy in a variety of small animal models as a post-doctoral fellow at the University of California Los Angeles (UCLA). He is currently Director of Preclinical Imaging in the Crump Institute for Molecular Imaging, and Assistant Professor of Molecular and Medical Pharmacology at UCLA.

  • Ph.D
  • The Alavi-Mandell Award, Society of Nuclear Medicine and Molecular Imaging, 2020.
  • The Hirshberg Foundation Seed Grant Award, The Hirshberg Foundation, 2018.
  • Best Postdoctoral Research Presentation Award, UCLA, 2017.
  • The Horizon Award, US Department of Defense, 2016.
  • Best Research Poster Presentation Award, UCLA, 2015.
  • GPSAW Award for Best Graduate Research, University of Southern California, 2013.
  • Outstanding Research Assistant Award, University of Southern California, 2013.
  • Phi Kappa Phi Student Recognition Award, University of Southern California, 2013.
  • The 1st Prize in Annual Graduate STEM Research Competition, University of Southern California, 2013.
  • The 1st Prize in Research Poster Presentation, University of Southern California, 2012.
  • Outstanding Teaching Assistant Award, University of Southern California, 2009.
  • President’s Undergraduate Research Fellowship, Peking University, 2006.
  • Jia-Li Scholarship, Peking University, 2005.
  • Guang-Hua Scholarship, Peking University, 2004.